- Home
- CYCN vs GSIW Comparison
CYCN vs GSIW Comparison
Compare CYCN & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCN
- GSIW
- Stock Information
- Founded
- CYCN 2018
- GSIW 2016
- Country
- CYCN United States
- GSIW Hong Kong
- Employees
- CYCN N/A
- GSIW N/A
- Industry
- CYCN Biotechnology: Pharmaceutical Preparations
- GSIW
- Sector
- CYCN Health Care
- GSIW
- Exchange
- CYCN Nasdaq
- GSIW Nasdaq
- Market Cap
- CYCN 8.5M
- GSIW 8.6M
- IPO Year
- CYCN N/A
- GSIW 2023
- Fundamental
- Price
- CYCN $3.32
- GSIW $0.58
- Analyst Decision
- CYCN
- GSIW
- Analyst Count
- CYCN 0
- GSIW 0
- Target Price
- CYCN N/A
- GSIW N/A
- AVG Volume (30 Days)
- CYCN 9.1M
- GSIW 156.5K
- Earning Date
- CYCN 11-14-2024
- GSIW 12-31-2024
- Dividend Yield
- CYCN N/A
- GSIW N/A
- EPS Growth
- CYCN N/A
- GSIW N/A
- EPS
- CYCN N/A
- GSIW N/A
- Revenue
- CYCN $194,000.00
- GSIW $1,408,469.00
- Revenue This Year
- CYCN N/A
- GSIW N/A
- Revenue Next Year
- CYCN N/A
- GSIW N/A
- P/E Ratio
- CYCN N/A
- GSIW N/A
- Revenue Growth
- CYCN N/A
- GSIW N/A
- 52 Week Low
- CYCN $1.27
- GSIW $0.52
- 52 Week High
- CYCN $9.47
- GSIW $15.99
- Technical
- Relative Strength Index (RSI)
- CYCN 52.12
- GSIW 33.82
- Support Level
- CYCN $2.80
- GSIW $0.52
- Resistance Level
- CYCN $3.43
- GSIW $0.60
- Average True Range (ATR)
- CYCN 0.71
- GSIW 0.05
- MACD
- CYCN -0.07
- GSIW 0.03
- Stochastic Oscillator
- CYCN 19.26
- GSIW 4.82
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.